Data search
Results for MligTC455_16789
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_16789 | 117 | 2.43 | Mlig455_015040, Mlig455_038611 | Neo: - |
Mlig455_015040 {REF} {Length: 2086} {RNA1509_51913} {RNA1310_36218} {RNA815_16479.1} Mlig455_038611 {REF} {Length: 2277} {RNA1509_51913, RNA1509_56625} {RNA1310_36218, RNA1509_56625} {RNA1509_56625, RNA815_16479.1} |
Cumulative graph for MligTC455_16789
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | 2.677 | 2.294 | 0.33952 | 0.98458 | |
| RegionR2 | -1.661 | 2.294 | 0.13712 | 0.46015 | |
| RegionR3 | 0.631 | 2.294 | 0.43548 | 0.95294 | |
| RegionR4 | 2.567 | 2.294 | 0.03513 | 0.15182 | |
| RegionR5 | -0.463 | 2.294 | 0.49649 | 0.85986 | |
| RegionR6 | -1.822 | 2.294 | 0.04549 | 0.39844 | |
| RegionR7 | -0.496 | 2.294 | 0.61662 | 1.00000 | |
| RegionR8 | -1.433 | 2.294 | 0.29231 | 0.92091 |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | -5.351 | 2.294 | 0.38023 | 1.00000 | |
| RegenerationR2 | -0.129 | 2.294 | 0.88855 | 1.00000 | |
| RegenerationR3 | -0.815 | 2.294 | 0.37764 | 0.78917 | |
| RegenerationR4 | -1.483 | 2.294 | 0.17809 | 0.61786 | |
| RegenerationR5 | -1.108 | 2.294 | 0.20841 | 0.64207 | |
| RegenerationR6 | 1.256 | 2.294 | 0.21157 | 0.55499 | |
| RegenerationBL | -3.13 | 2.294 | 0.25189 | 0.60822 | |
| RegenerationTP | -1.87 | 2.294 | 0.22077 | 0.66434 |
Genes with expression patterns similar to MligTC455_16789
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_16789 | 117 | 2.43 | Mlig455_015040, Mlig455_038611 | Neo: - |
5 | 1.000 | 1.000 | - | 1.000 | 1.000 | 1.000 | Mlig455_015040 {REF} {Length: 2086} {RNA1509_51913} {RNA1310_36218} {RNA815_16479.1} Mlig455_038611 {REF} {Length: 2277} {RNA1509_51913, RNA1509_56625} {RNA1310_36218, RNA1509_56625} {RNA1509_56625, RNA815_16479.1} |
|
| 2. | MligTC455_16788 | 59 | 1.24 | Mlig455_038466 | Neo: - Age: - |
3.996 | 0.998 | 1.000 | - | - | 1.000 | 0.998 | Mlig455_038466 {REF} {Length: 2221} {RNA1509_51913} {RNA1310_36218} {RNA815_16479.1} | |
| 3. | MligTC455_16790 | 46 | 0.97 | Mlig455_038405 | Neo: - Age: - |
1.951 | 0.980 | 0.971 | - | - | - | - | Mlig455_038405 {REF} {Length: 1884} {RNA1509_51913} {RNA1310_36218, RNA1509_51913} {RNA1509_51913, RNA815_16479.1} | |
| 4. | MligTC455_29276 | 183 | 3.81 | Mlig455_035308 | Neo: - Age: - |
CYP3A7 | 1.802 | - | - | - | 0.844 | 0.958 | - | Mlig455_035308 {REF} {Length: 2558} {Pfam: Cytochrome P450 [PF00067.24, score=303.7]} {Human: ENSG00000160870, CYP3A7, cytochrome P450 family 3 subfamily A member 7, [Score=269, Expect=1e-83]; ENSG00000282301, CYP3A7-CYP3A51P, CYP3A7-CYP3A51P readthrough, [Score=268, Expect=7e-83]; ENSG00000021461, CYP3A43, cytochrome P450 family 3 subfamily A member 43, [Score=259, Expect=3e-80]; ENSG00000160868, CYP3A4, cytochrome P450 family 3 subfamily A member 4, [Score=258, Expect=1e-79]} {Mouse: ENSMUSG00000029727, Cyp3a13, cytochrome P450, family 3, subfamily a, polypeptide 13, [Score=261, Expect=5e-81]; ENSMUSG00000056035, Cyp3a11, cytochrome P450, family 3, subfamily a, polypeptide 11, [Score=253, Expect=1e-77]; ENSMUSG00000029630, Cyp3a25, cytochrome P450, family 3, subfamily a, polypeptide 25, [Score=252, Expect=2e-77]; ENSMUSG00000075552, Cyp3a41b, cytochrome P450, family 3, subfamily a, polypeptide 41B, [Score=251, Expect=4e-77]; ENSMUSG00000061292, Cyp3a59, cytochrome P450, family 3, subfamily a, polypeptide 59, [Score=251, Expect=6e-77]; ENSMUSG00000075551, Cyp3a41a, cytochrome P450, family 3, subfamily a, polypeptide 41A, [Score=251, Expect=4e-77]; ENSMUSG00000054417, Cyp3a44, cytochrome P450, family 3, subfamily a, polypeptide 44, [Score=250, Expect=9e-77]; ENSMUSG00000038656, Cyp3a16, cytochrome P450, family 3, subfamily a, polypeptide 16, [Score=248, Expect=5e-76]} {Dmel: FBgn0013772, Cyp6a8, Cytochrome P450-6a8, [RH, Score=225, Expect=4e-67]} {Celegans: WBGene00011676, cyp-13A2, Putative cytochrome P450 CYP13A2, [Score=209, Expect=2e-61]} {Smed: dd_Smed_v6_10343_0_1, dd_Smed_v6_10343_0_1, [Score=307, Expect=6e-99]} {RNA1509_4674} {RNA1310_15246} {RNA815_7045} |
| 5. | MligTC455_34912 | 35 | 0.74 | Mlig455_024825 | Neo: Irradiation Age: - |
TADA2B | 0.988 | - | - | - | - | 0.988 | - | Mlig455_024825 {REF} {Length: 3952} {TRANSSPLICED} {Pfam: Myb-like DNA-binding domain [PF00249.33, score=36.9]} {Human: ENSG00000173011, TADA2B, transcriptional adaptor 2B, [RH, Score=161, Expect=3e-42]} {Mouse: ENSMUSG00000029196, Tada2b, transcriptional adaptor 2B, [RH, Score=161, Expect=2e-42]} {Dmel: FBgn0037555, Ada2b, transcriptional Adaptor 2b, [RH, Score=129, Expect=6e-31]} {Smed: dd_Smed_v6_7427_0_1, dd_Smed_v6_7427_0_1, [RH, Score=214, Expect=4e-61]} {RNA1509_11799} {RNA1310_29035} {RNA815_19546} |
| 6. | MligTC455_08701 | 18 | 0.37 | Mlig455_054805 | Neo: - Age: Down-Up-Down |
SLC5A12 | 0.987 | - | - | - | - | 0.987 | - | Mlig455_054805 {REF} {Length: 2561} {Pfam: Sodium:solute symporter family [PF00474.19, score=101.1]} {Human: ENSG00000148942, SLC5A12, solute carrier family 5 member 12, [Score=302, Expect=4e-94]; ENSG00000262217, SLC5A8, solute carrier family 5 member 8, [Score=300, Expect=1e-93]; ENSG00000256870, SLC5A8, solute carrier family 5 member 8, [Score=300, Expect=1e-93]} {Mouse: ENSMUSG00000020062, Slc5a8, solute carrier family 5 (iodide transporter), member 8, [Score=308, Expect=1e-96]} {Dmel: FBgn0017448, CG2187, [Score=265, Expect=3e-80]} {Celegans: WBGene00014092, ZK822.5, [Score=190, Expect=9e-53]} {Smed: dd_Smed_v6_14173_0_1, dd_Smed_v6_14173_0_1, [Score=272, Expect=2e-83]} {RNA1509_38187} {RNA1310_11800.1} {RNA815_9373} |
| 7. | MligTC455_02120 | 16 | 0.34 | Mlig455_008013 | Neo: - Age: - |
0.985 | - | - | - | - | 0.985 | - | Mlig455_008013 {REF} {Length: 1069} {RNA1509_28842} {RNA1310_46896} {RNA815_34630} | |
| 8. | MligTC455_14437 | 27 | 0.56 | Mlig455_042114 | Neo: - Age: Up-Down-Down |
RIMS2 | 0.978 | - | - | - | 0.978 | - | - | Mlig455_042114 {REF} {Length: 5253} {Pfam: C2 domain [PF00168.32, score=108.2]; PDZ domain [PF17820.3, score=36.6]; PDZ domain [PF00595.26, score=26.1]} {Human: ENSG00000176406, RIMS2, regulating synaptic membrane exocytosis 2, [RH, Score=240, Expect=1e-63]} {Mouse: ENSMUSG00000037386, Rims2, regulating synaptic membrane exocytosis 2, [RH, Score=239, Expect=1e-63]} {Dmel: FBgn0053547, Rim, Rab3 interacting molecule, [RH, Score=244, Expect=7e-65]} {Celegans: WBGene00006750, unc-10, Rab-3-interacting molecule unc-10, [RH, Score=184, Expect=9e-47]} {Smed: dd_Smed_v6_15437_0_1, dd_Smed_v6_15437_0_1, [RH, Score=253, Expect=3e-68]} {RNA1509_30202} {RNA1310_7188} {RNA815_33679} |
| 9. | MligTC455_12925 | 116 | 2.41 | Mlig455_024514 | Neo: - Age: - Region-enriched R4: 2.542/0.00358 |
0.971 | - | - | - | - | 0.971 | - | Mlig455_024514 {REF} {Length: 967} {NoTransDecoderORF} {RNA1509_41511} {RNA1310_36444} {RNA815_25464} | |
| 10. | MligTC455_32149 | 36 | 0.75 | Mlig455_033666 | Neo: - Age: Up-Down-Up |
0.97 | - | - | - | - | 0.970 | - | Mlig455_033666 {REF} {Length: 2371} {Pfam: Ribosomal protein S31e [PF17067.7, score=24.1]} {RNA1509_26752} {RNA1310_51800} {RNA815_53946} | |
| 11. | MligTC455_15786 | 7 | 0.15 | Mlig455_012467 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_012467 {REF} {Length: 502} {NoTransDecoderORF} {RNA1509_30577} {RNA1310_42146.2} {RNA815_12832} | |
| 12. | MligTC455_47223 | 169 | 3.52 | Mlig455_044907 | Neo: - Age: Down-Down-Up |
RAB9A | 0.965 | - | - | - | 0.965 | - | - | Mlig455_044907 {REF} {Length: 3923} {TRANSSPLICED} {Pfam: Ras family [PF00071.24, score=172.2]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=111.6]; ADP-ribosylation factor family [PF00025.23, score=38.7]; Gtr1/RagA G protein conserved region [PF04670.14, score=22.4]; 50S ribosome-binding GTPase [PF01926.25, score=20.0]; RsgA GTPase [PF03193.18, score=20.0]} {Human: ENSG00000123595, RAB9A, RAB9A, member RAS oncogene family, [RH, Score=194, Expect=3e-62]; ENSG00000123570, RAB9B, RAB9B, member RAS oncogene family, [RH, Score=193, Expect=5e-62]} {Mouse: ENSMUSG00000079316, Rab9, RAB9, member RAS oncogene family, [RH, Score=195, Expect=6e-63]; ENSMUSG00000043463, Rab9b, RAB9B, member RAS oncogene family, [RH, Score=192, Expect=1e-61]} {Dmel: FBgn0032782, Rab9, [RH, Score=191, Expect=8e-61]} {Celegans: WBGene00004271, rab-7, RAB family, [Score=153, Expect=1e-46]} {Smed: dd_Smed_v6_6588_0_1, dd_Smed_v6_6588_0_1, [RH, Score=159, Expect=1e-48]} {RNA1509_39673} {RNA1310_43480, RNA1509_39673} {RNA1509_39673, RNA815_29088} |
| 13. | MligTC455_47224 | 169 | 3.52 | Mlig455_044959 | Neo: - Age: - |
RAB9A | 0.965 | - | - | - | 0.965 | - | - | Mlig455_044959 {REF} {Length: 3015} {TRANSSPLICED} {Pfam: Ras family [PF00071.24, score=125.0]; Ras of Complex, Roc, domain of DAPkinase [PF08477.15, score=71.2]; RsgA GTPase [PF03193.18, score=21.6]; AAA ATPase domain [PF13191.8, score=19.6]} {Human: ENSG00000123595, RAB9A, RAB9A, member RAS oncogene family, [Score=163, Expect=2e-50]; ENSG00000123570, RAB9B, RAB9B, member RAS oncogene family, [Score=162, Expect=5e-50]} {Mouse: ENSMUSG00000079316, Rab9, RAB9, member RAS oncogene family, [Score=164, Expect=3e-51]; ENSMUSG00000043463, Rab9b, RAB9B, member RAS oncogene family, [Score=160, Expect=1e-49]} {Dmel: FBgn0032782, Rab9, [Score=153, Expect=4e-46]} {Celegans: WBGene00004271, rab-7, RAB family, [Score=120, Expect=3e-34]} {Smed: dd_Smed_v6_6588_0_1, dd_Smed_v6_6588_0_1, [Score=131, Expect=4e-38]} {RNA1509_39673, RNA1509_40920} {RNA1310_41092, RNA1509_40920} {RNA1509_40920, RNA815_29088} |
| 14. | MligTC455_38688 | 33 | 0.69 | Mlig455_043147 | Neo: - Age: - Region-enriched R6: 4.661/0.04231 |
RREB1 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_043147 {REF} {Length: 3281} {Pfam: Zinc-finger double domain [PF13465.8, score=38.3]; C2H2-type zinc finger [PF13894.8, score=37.2]; Zinc finger, C2H2 type [PF00096.28, score=20.5]} {Human: ENSG00000124782, RREB1, ras responsive element binding protein 1, [Score=90.9, Expect=7e-18]} {Mouse: ENSMUSG00000039087, Rreb1, ras responsive element binding protein 1, [Score=91.3, Expect=4e-18]} {Dmel: FBgn0003053, peb, pebbled, [Score=77.8, Expect=4e-14]} {Celegans: WBGene00013240, Y56A3A.28, [Score=60.1, Expect=3e-09]} {Smed: dd_Smed_v6_10103_0_1, dd_Smed_v6_10103_0_1, [RH, Score=129, Expect=3e-31]} {RNA1509_36287} {RNA1310_1106.1} {RNA815_1479.1} |
| 15. | MligTC455_35675 | 12 | 0.26 | Mlig455_024961 | Neo: - Age: - |
0.953 | - | - | - | - | 0.953 | - | Mlig455_024961 {REF} {Length: 1271} {TRANSSPLICED} {RNA1509_15887} {RNA1310_1901} {RNA815_7161} | |
| 16. | MligTC455_23240 | 7 | 0.14 | Mlig455_016018, Mlig455_017540, Mlig455_017571, Mlig455_026829 | Neo: - Age: logFC(26M/2M)=-0.900 |
GALR2, PRKCB | 0.952 | - | - | - | - | 0.952 | - | Mlig455_016018 {REF} {Length: 1434} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=170.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=53.2]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=44.6]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=34.8]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=18.5]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=148, Expect=5e-40]; ENSG00000112038, OPRM1, opioid receptor mu 1, [Score=146, Expect=2e-38]} {Mouse: ENSMUSG00000025905, Oprk1, opioid receptor, kappa 1, [Score=149, Expect=1e-40]; ENSMUSG00000000766, Oprm1, opioid receptor, mu 1, [Score=145, Expect=7e-39]; ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=145, Expect=4e-39]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=208, Expect=5e-63]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=187, Expect=2e-54]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=252, Expect=2e-79]} Mlig455_017540 {REF} {Length: 3096} {Pfam: Protein kinase domain [PF00069.27, score=226.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=129.3]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=118.5]; C2 domain [PF00168.32, score=93.9]; Protein kinase C terminal domain [PF00433.26, score=35.4]; C1 domain [PF03107.18, score=22.2]; Kinase-like [PF14531.8, score=18.2]} {Human: ENSG00000166501, PRKCB, protein kinase C beta, [RH, Score=963, Expect=0.0]; ENSG00000154229, PRKCA, protein kinase C alpha, [RH, Score=949, Expect=0.0]} {Mouse: ENSMUSG00000052889, Prkcb, protein kinase C, beta, [RH, Score=962, Expect=0.0]; ENSMUSG00000050965, Prkca, protein kinase C, alpha, [RH, Score=949, Expect=0.0]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [RH, Score=941, Expect=0.0]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [RH, Score=940, Expect=0.0]} {Smed: dd_Smed_v6_4244_0_2, dd_Smed_v6_4244_0_2, [RH, Score=1051, Expect=0.0]} {RNA1509_51260} {RNA1310_9698} {RNA815_24870} Mlig455_017571 {REF} {Length: 2223} {Pfam: Protein kinase domain [PF00069.27, score=179.7]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=117.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=96.0]; C2 domain [PF00168.32, score=95.2]; Protein kinase C terminal domain [PF00433.26, score=35.4]; C1 domain [PF03107.18, score=21.0]} {Human: ENSG00000166501, PRKCB, protein kinase C beta, [Score=896, Expect=0.0]; ENSG00000154229, PRKCA, protein kinase C alpha, [Score=889, Expect=0.0]} {Mouse: ENSMUSG00000052889, Prkcb, protein kinase C, beta, [Score=896, Expect=0.0]; ENSMUSG00000050965, Prkca, protein kinase C, alpha, [Score=889, Expect=0.0]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [Score=860, Expect=0.0]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [Score=871, Expect=0.0]} {Smed: dd_Smed_v6_4464_0_1, dd_Smed_v6_4464_0_1, [Score=963, Expect=0.0]} {RNA1509_51260} {RNA1310_9698} {RNA815_24870} Mlig455_026829 {REF} {Length: 2027} {Pfam: Protein kinase domain [PF00069.27, score=226.0]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=129.5]; Phorbol esters/diacylglycerol binding domain (C1 domain) [PF00130.24, score=116.8]; C2 domain [PF00168.32, score=95.1]; Protein kinase C terminal domain [PF00433.26, score=35.3]; C1 domain [PF03107.18, score=20.8]; Kinase-like [PF14531.8, score=18.2]} {Human: ENSG00000166501, PRKCB, protein kinase C beta, [RH, Score=959, Expect=0.0]; ENSG00000154229, PRKCA, protein kinase C alpha, [RH, Score=947, Expect=0.0]} {Mouse: ENSMUSG00000052889, Prkcb, protein kinase C, beta, [RH, Score=959, Expect=0.0]; ENSMUSG00000050965, Prkca, protein kinase C, alpha, [RH, Score=948, Expect=0.0]} {Dmel: FBgn0003091, Pkc53E, Protein C kinase 53E, [Score=928, Expect=0.0]} {Celegans: WBGene00004033, pkc-2, Protein kinase C-like 2, [RH, Score=939, Expect=0.0]} {Smed: dd_Smed_v6_4244_0_2, dd_Smed_v6_4244_0_2, [RH, Score=1049, Expect=0.0]} {RNA1509_51260} {RNA1310_9698} {RNA815_24870} |
| 17. | MligTC455_34881 | 28 | 0.57 | Mlig455_006956 | Neo: - Age: Up-Down-Down |
0.952 | - | - | - | - | 0.952 | - | Mlig455_006956 {REF} {Length: 5602} {Pfam: CD80-like C2-set immunoglobulin domain [PF08205.14, score=27.1]; Immunoglobulin domain [PF13927.8, score=21.7]} {Dmel: FBgn0024189, sns, sticks and stones, [Score=54.7, Expect=8e-07]} {RNA1509_31973} {RNA1310_5137.1} {RNA815_24486} | |
| 18. | MligTC455_03079 | 157 | 3.27 | Mlig455_038516, Mlig455_052234 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.732 Region-enriched R4: 5.623/0.00001 |
0.951 | - | - | - | - | 0.951 | - | Mlig455_038516 {REF} {Length: 1502} {Pfam: Glycolipid 2-alpha-mannosyltransferase [PF01793.18, score=115.3]} {RNA1509_55347} {RNA1310_24586} {RNA815_10520} Mlig455_052234 {REF} {Length: 1512} {Pfam: Glycolipid 2-alpha-mannosyltransferase [PF01793.18, score=115.3]} {RNA1509_55347} {RNA1310_24586, RNA1509_55347} {RNA1509_55347, RNA815_10520} |
|
| 19. | MligTC455_25865 | 96 | 2 | Mlig455_008643, Mlig455_069411 | Neo: - Age: - Region-enriched R2: 7.383/0.00023 |
SETMAR | 0.95 | - | - | - | 0.950 | - | - | Mlig455_008643 {REF} {Length: 1815} {Pfam: Transposase (partial DDE domain) [PF01359.20, score=48.0]; HTH domain in Mos1 transposase [PF17906.3, score=34.1]; Homeodomain-like domain [PF13565.8, score=28.7]; Transposase [PF01498.20, score=21.5]; Winged helix-turn-helix DNA-binding [PF13412.8, score=20.0]; AsnC-type helix-turn-helix domain [PF13404.8, score=19.2]; Winged helix-turn helix [PF13551.8, score=18.7]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=135, Expect=7e-35]} {Smed: dd_Smed_v6_16659_0_1, dd_Smed_v6_16659_0_1, [RH, Score=50.1, Expect=1e-07]} {RNA1509_35414} {RNA1310_3855.1} {RNA815_19895} Mlig455_069411 {REF} {Length: 1815} {Pfam: Transposase (partial DDE domain) [PF01359.20, score=47.9]; HTH domain in Mos1 transposase [PF17906.3, score=34.2]; Homeodomain-like domain [PF13565.8, score=28.7]; Transposase [PF01498.20, score=21.5]; Winged helix-turn-helix DNA-binding [PF13412.8, score=20.0]; AsnC-type helix-turn-helix domain [PF13404.8, score=19.2]; Winged helix-turn helix [PF13551.8, score=18.7]} {Human: ENSG00000170364, SETMAR, SET domain and mariner transposase fusion gene, [Score=135, Expect=9e-35]} {Smed: dd_Smed_v6_16659_0_1, dd_Smed_v6_16659_0_1, [RH, Score=50.1, Expect=1e-07]} {RNA1509_35414} {RNA1310_3855.1} {RNA815_19895} |